The cost-effectiveness of antenatal varicella screening with post-partum vaccination of susceptibles

被引:15
作者
de Moira, AP
Edmunds, WJ
Breuer, J
机构
[1] St Barts & London Hosp, Skin Virus Lab, Inst Cell & Mol Sci, Sch Med, London E1 1BB, England
[2] Hlth Protect Agcy, Ctr Infect, Modelling & Econ Unit, London NW9 5EQ, England
关键词
varicella-zoster virus; vaccination; cost-effectiveness;
D O I
10.1016/j.vaccine.2005.09.028
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Varicella infection during pregnancy or around the time of birth can result in serious complications for the mother and/or her child. However, infection during pregnancy is relatively rare as most women are infected during childhood. Immigrant mothers from certain tropical countries are at increased risk of infection, as these countries appear to have lower rates of infection during childhood. We used a cohort model to assess the potential costs and benefits of screening first-time pregnant mothers and then vaccinating those who are susceptible. The model was stratified by age and country of birth (Bangladesh or UK). The strategies evaluated were: (a) an initial verbal screen followed by a serological screen for those with a negative or uncertain history, (b) universal serological screening; and (c) the current strategy which is to treat cases as they arise. Post-partum vaccination was given to those who screen negative for VZV antibodies. The model suggested that the screening and vaccination strategies prevent cases in women compared with the current strategy. Verbal followed by serological screening may be cost-saving to the NHS for both UK- and Bangladesh-born women. Universal screening is more costly but more effective than verbal screening, and it may be cost-effective to universally screen younger immigrant mothers. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1298 / 1307
页数:10
相关论文
共 39 条
[1]  
ANNUNZIATO PA, 2000, VARICELLA ZOSTER VIR, P460
[2]  
Brisson M., 2003, Journal of Medical Virology, V70, pS9, DOI 10.1002/jmv.10313
[3]   Varicella vaccination in England and Wales: cost-utility analysis [J].
Brisson, M ;
Edmunds, WJ .
ARCHIVES OF DISEASE IN CHILDHOOD, 2003, 88 (10) :862-869
[4]   Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox [J].
Brisson, M ;
Gay, NJ ;
Edmunds, WJ ;
Andrews, NJ .
VACCINE, 2002, 20 (19-20) :2500-2507
[5]   Epidemiology of varicella zoster virus infection in Canada and the United Kingdom [J].
Brisson, M ;
Edmunds, WJ ;
Law, B ;
Gay, NJ ;
Walld, R ;
Brownell, M ;
Roos, L ;
De Serres, G .
EPIDEMIOLOGY AND INFECTION, 2001, 127 (02) :305-314
[6]  
*BRIT MED ASS ROYA, 2004, BRIT NAT FORM
[7]  
*DEP HLTH, 2002, HOSP EP STAT 2000 20
[8]   Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis [J].
Devlin, N ;
Parkin, D .
HEALTH ECONOMICS, 2004, 13 (05) :437-452
[9]   CONSEQUENCES OF VARICELLA AND HERPES-ZOSTER IN PREGNANCY - PROSPECTIVE-STUDY OF 1739 CASES [J].
ENDERS, G ;
MILLER, E ;
CRADOCKWATSON, J ;
BOLLEY, I ;
RIDEHALGH, M .
LANCET, 1994, 343 (8912) :1548-1551
[10]  
Enders G., 2000, Varicella-zoster virus, P317, DOI [10.1017/CBO9780511601194, DOI 10.1017/CBO9780511601194]